{
    "code": "02018613",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018613",
    "time": "2016-06-24 04:10:54",
    "許可證字號": "衛署藥輸字第018613號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/05\/23",
    "發證日期": "80\/05\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201861307",
    "中文品名": "\"速溶\" 艾黴素注射劑５０公絲",
    "英文品名": "ADRIBLASTINA RAPID DISSOLUTION 50MG",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": {
        "製造廠名稱": "F250307000  ACTAVIS ITALY S.P.A.",
        "製造廠廠址": "NERVIANO-VIALE PASTEUR N.10, MILANO,20014 ITALY",
        "製造廠公司地址": "VIA R. KOCH 1.2, 20152, MILAN, ITALY",
        "製造廠國別": "ITALY",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Adriblastina Rapid Dissolution 50mg 藥輸018613-103-04-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018613&Seq=001&Type=9"
        }
    ]
}